Pregnancy with heart valve diseases

doi:10.3877/cma.j.issn.2095-3259.2022.02.001

Abstract

Abstract:

Valvular heart disease is still an important part of pregnant women with heart diseases. Hemodynamic changes during pregnancy can worsen heart function in these women and then result in maternal and fetal mortality and morbidity. Individual management and close monitoring are indicated during pregnancy depending on the part and type of valve lesions, which is helpful to reduce maternal and fetal complications and to increasing the safety of pregnancy in these women.

Key words: Heart valve diseases, Pregnant, Pregnancy outcome

Huixian Liao, Jianhua Lin. Pregnancy with heart valve diseases[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2022, 11(02): 65-71.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2022.02.001

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2022/V11/I02/65

Figures/Tables 5

References 35

[1]	Siu SC, Sermer M, Colman JM, et al. Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease [J]. Circulation, 2001，104(5)：515-521.
[2]	Roos-Hesselink JW, Ruys TP, Stein JI, et al. ROPAC Investigators. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology [J]. Eur Heart J, 2013，34(9)：657-665.
[3]	Hu J, Ye Y, Lu A, et al. Pregnancy Outcomes in Patients With Heart Disease in China [J]. Am J Cardiol, 2020，125(11)：1718-1724.
[4]	Fu Q, Wang XJ, Wang BS, et al. Cardiac risk prediction model for pregnant women with structural heart disease in Eastern China [J]. Int J Gynaecol Obstet, 2019，145(3)：324-330.
[5]	Soler-Soler J, Galve E. Worldwide perspective of valve disease [J]. Heart, 2000，83(6)：721-725.
[6]	Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases [J]. Lancet Infect Dis, 2005，5(11)：685-694.
[7]	Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy [J]. Br Heart J, 1992，68(6)：540-543.
[8]	Nishimura RA, Otto CM, Bonow RO，et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J]. J Am Coll Cardiol, 2014，63(22)：2438-2488.
[9]	Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance [J]. J Am Soc Echocardiogr, 2017，30(4)：303-371.
[10]	Baumgartner H, Hung J, Bermejo J, et al. American Society of Echocardiography; European Association of Echocardiography. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice [J]. J Am Soc Echocardiogr, 2009，22(1)：1-23.
[11]	Pessel C, Bonanno C. Valve disease in pregnancy [J]. Semin Perinatol, 2014，38(5)：273-284.
[12]	Lau ES, Scott NS. Valvular Heart Disease and Pregnancy [J]. Curr Treat Options Cardiovasc Med, 2018，20(6)：46.
[13]	van Hagen IM, Thorne SA, Taha N, et al. ROPAC Investigators and EORP Team. Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease [J]. Circulation, 2018，137(8)：806-816.
[14]	Orwat S, Diller GP, van Hagen IM, et al. Risk of Pregnancy in Moderate and Severe Aortic Stenosis: From the Multinational ROPAC Registry [J]. J Am Coll Cardiol, 2016，68(16)：1727-1737.
[15]	Yap SC, Drenthen W, Pieper PG, et al. ZAHARA investigators. Risk of complications during pregnancy in women with congenital aortic stenosis [J]. Int J Cardiol, 2008，126(2)：240-246.
[16]	Lui GK, Silversides CK, Khairy P, et al. Heart rate response during exercise and pregnancy outcome in women with congenital heart disease [J]. Circulation，2011，123(3)：242-248.
[17]	Ohuchi H, Tanabe Y, Kamiya C, et al. Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease [J]. Circ J, 2013，77(2)：470-476.
[18]	Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis[J]. Heart, 2006，92(12)：1838-1843.
[19]	Sliwa K, Johnson MR, Zilla P, et al. Management of valvular disease in pregnancy: a global perspective [J]. Eur Heart J, 2015，36(18)：1078-1089.
[20]	Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2013，14(7): 611-644.
[21]	Khairy P, Ouyang DW, Fernandes SM, et al. Pregnancy outcomes in women with congenital heart disease [J]. Circulation, 2006，113(4)：517-524.
[22]	Vause S, Clarke B, Tower CL, et al. Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system [J]. BJOG, 2017，124(9)：1411-1419.
[23]	van Hagen IM, Roos-Hesselink JW, Ruys TP, et al. Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC) [J]. Circulation, 2015，132(2)：132-142.
[24]	Jamieson WR, Rosado LJ, Munro AI, et al. Carpentier-Edwards standard porcine bioprosthesis: primary tissue failure (structural valve deterioration) by age groups [J]. Ann Thorac Surg, 1988，46(2)：155-162.
[25]	刘石萍，陈倩. 风湿性心脏病瓣膜置换术后妊娠风险及对策[J]. 中国实用妇科与产科杂志，2019，35(11)：1210-1213.
[26]	Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy [J]. Eur Heart J, 2018，39(34)：3165-3241.
[27]	American College of Obstetricians and Gynecologists′ Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No.212: Pregnancy and Heart Disease [J]. Obstet Gynecol, 2019，133(5)：e320-e356.
[28]	中华医学会妇产科学分会产科学组. 妊娠合并心脏病的诊治专家共识(2016)[J]. 中华妇产科杂志，2016，51(6)：401-409
[29]	柳艳丽，韩凤珍，庄建，等. 妊娠期心脏病孕妇手术及介入治疗结局分析[J]. 中华妇产科杂志，2020，55(7)：465-470.
[30]	Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature [J]. Arch Intern Med, 2000，160(2)：191-196.
[31]	Cotrufo M, De Feo M, De Santo LS, et al. Risk of warfarin during pregnancy with mechanical valve prostheses [J]. Obstet Gynecol, 2002，99(1)：35-40.
[32]	D′Souza R, Ostro J, Shah PS, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis [J]. Eur Heart J, 2017，38(19)：1509-1516.
[33]	Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease [J]. Eur Heart J, 2017，38(36): 2739-2791.
[34]	付博，董力，石应康，等．中国人心脏瓣膜置换术后抗凝治疗数据库建设[J]. 中国胸心血管外科临床杂志，2013，20(1)：3-9.
[35]	Hutt E, Desai MY. Management of valvular heart disease in the pregnant patient [J]. Expert Rev Cardiovasc Ther, 2020，18(8)：495-501.

二尖瓣关闭不全严重程度	二尖瓣瓣口面积(cm²)	舒张压差减半时间(ms)	平均压力差(mmHg)	肺动脉收缩压(mmHg)
轻度	>1.5	<150	<5	<30
中度	1.0~1.5	≥150	5~10	>30
重度	≤1.0	≥150，≥220为极重度	>10	>30

二尖瓣关闭不全严重程度	二尖瓣瓣口面积(cm²)	舒张压差减半时间(ms)	平均压力差(mmHg)	肺动脉收缩压(mmHg)
轻度	>1.5	<150	<5	<30
中度	1.0~1.5	≥150	5~10	>30
重度	≤1.0	≥150，≥220为极重度	>10	>30

严重程度	主动脉瓣瓣口面积(cm²)	平均压力差(mmHg)	主动脉瓣峰值流速(m/s)	瓣口面积指数(cm²/m²)
轻度	>1.5	<20	2.0~2.9	>0.85
中度	1.0~1.5	20~39	3.0~3.9	0.6~0.85
重度	≤1.0	≥40	≥4.0	≤0.6

严重程度	主动脉瓣瓣口面积(cm²)	平均压力差(mmHg)	主动脉瓣峰值流速(m/s)	瓣口面积指数(cm²/m²)
轻度	>1.5	<20	2.0~2.9	>0.85
中度	1.0~1.5	20~39	3.0~3.9	0.6~0.85
重度	≤1.0	≥40	≥4.0	≤0.6

严重程度	EROA(cm²)	反流量(ml)	反流分数(%)	反流面积/左心房面积(%)	流颈宽度(cm)
轻度	<0.20	<30	NA	<20	<0.3
中度	<0.40	<60	<50	20~40	<0.7
重度	≥0.40	≥60	≥50	>40	≥0.7

Please choose a citation manager

Content to export